Calcium Channel Blockers in the Treatment of Disease

Journal of Neuroscience Research

Volumn 75, Issue 6, 2004, Pages 733-741

  Elmslie, Keith S ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Chronic pain; Conotoxins; Dihydropyridines; Epilepsy; Hypertension

Indexed keywords

AM 336; AMLODIPINE; ANTIARRHYTHMIC AGENT; ANTIHISTAMINIC AGENT; BENZOTHIAZEPINE DERIVATIVE; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL N TYPE; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; CALCIUM CHANNEL R TYPE; CALCIUM CHANNEL T TYPE; DIHYDROPYRIDINE DERIVATIVE; ETHOSUXIMIDE; GABAPENTIN; METHYLPHENYLSUCCINIMIDE; MIBEFRADIL; NICKEL; NIFEDIPINE; OMEGA AGATOXIN IVA; OMEGA AGATOXIN VIA; OMEGA CONOTOXIN; OMEGA CONOTOXIN CVID; OMEGA CONOTOXIN GVIA; OMEGA CONOTOXIN MVIIA; OMEGA CONOTOXIN MVIIC; PHENYLALKYLAMINE; PROTEIN SUBUNIT; SNX 482; SUCCINIMIDE DERIVATIVE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG;

CARDIOVASCULAR DISEASE; CHRONIC PAIN; CLINICAL TRIAL; DRUG EFFECT; DRUG MECHANISM; DRUG SPECIFICITY; EPILEPSY; HUMAN; HYPERTENSION; MOLECULAR BIOLOGY; NEUROLOGIC DISEASE; NEUROPATHIC PAIN; NONHUMAN; PATCH CLAMP; PREMATURE LABOR; PRIORITY JOURNAL; SHORT SURVEY; SIDE EFFECT;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CARDIOVASCULAR DISEASES; FORECASTING; HUMANS; NERVOUS SYSTEM DISEASES; PAIN;

EID: 1542274327     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10872     Document Type: Short Survey

References (109)

1. Adams DJ, Smith AB, Schroeder CI, Yasuda T, Lewis RJ. 2003. ω-Conotoxin CVID inhibits a pharmacologically distinct voltage-sensitive calcium channel associated with transmitter release from preganglionic nerve terminals. J Biol Chem 278:4057-4062.
2. Arikkath J, Campbell KP. 2003. Auxiliary subunits: essential components of the voltage-gated calcium channel complex. Curr Opin Neurobiol 13:298-307.
3. Bao J, Li JJ, Perl ER. 1998. Differences in Ca2+ channels governing generation of miniature and evoked excitatory synaptic currents in spinal laminae I and II. J Neurosci 18:8740-8750.
4. Barclay J, Balaguero N, Mione M, Ackerman SL, Letts VA, Brodbeck J, Canti C, Meir A, Page KM, Kusumi K, Perez-Reyes E, Lander ES, Frankel WN, Gardiner RM, Dolphin AC, Rees M. 2001. Ducky mouse phenotype of epilepsy and ataxia is associated with mutations in the Cacna2d2 gene and decreased calcium channel current in cerebellar Purkinje cells. J Neurosci 21:6095-6104.
5. Bean BP. 1984. Nitrendipine block of cardiac calcium channels: high-affinity binding to the inactivated state. Proc Natl Acad Sci USA 81:6388-6392.
6. Bech-Hansen NT, Naylor MJ, Maybaum TA, Pearce WG, Koop B, Fishman GA, Mets M, Musarella MA, Boycott KM. 1998. Loss-of-function mutations in a calcium-channel alpha1-subunit gene in Xp11.23 cause incomplete X-linked congenital stationary night blindness. Nat Genet 19:264-267.
7. Bers DM, Perez-Reyes E. 1999. Ca channels in cardiac myocytes: structure and function in Ca influx and intracellular Ca release. Cardiovasc Res 42:339-360.
8. Bertolino M, Llinas RR. 1992. The central role of voltage-activated and receptor-operated calcium channels in neuronal cells. Annu Rev Pharmacol Toxicol 32:399-421.
9. Bijlenga P, Liu JH, Espinos E, Haenggeli CA, Fischer-Lougheed J, Bader CR, Bernheim L. 2000. T-type alpha 1H Ca2+ channels are involved in Ca2+ signaling during terminal differentiation (fusion) of human myoblasts. Proc Natl Acad Sci USA 97:7627-7632.
10. Boland LM, Bean BP. 1993. Modulation of N-type calcium channels in bullfrog sympathetic neurons by luteinizing hormone-releasing hormone: kinetics and voltage dependence. J Neurosci 13:516-533.
11. Boland LM, Morrill JA, Bean BP. 1994. Omega-conotoxin block of N-type calcium channels in frog and rat sympathetic neurons. J Neurosci 14:5011-5027.
12. Bourinet E, Soong TW, Sutton K, Slaymaker S, Mathews E, Monteil A, Zamponi GW, Nargeot J, Snutch TP. 1999. Splicing of alpha 1A subunit gene generates phenotypic variants of P- and Q-type calcium channels. Nat Neurosci 2:407-415.
13. Bridges D, Thompson SWN, Rice ASC. 2001. Mechanisms of neuropathic pain. Br J Anaesth 87:12-26.
14. Brodbeck J, Davies A, Courtney JM, Meir A, Balaguero N, Canti C, Moss FJ, Page KM, Pratt WS, Hunt SP, Barclay J, Rees M, Dolphin AC. 2002. The ducky mutation in Cacna2d2 results in altered Purkinje cell morphology and is associated with the expression of a truncated alpha 2 delta-2 protein with abnormal function. J Biol Chem 277:7684-7693.
15. Canti C, Davies A, Berrow NS, Butcher AJ, Page KM, Dolphin AC. 2001. Evidence for two concentration-dependent processes for beta-subunit effects on alpha1B calcium channels. Biophys J 81:1439-1451.
16. Catterall WA. 2000. Structure and regulation of voltage-gated Ca2+ channels. Annu Rev Cell Dev Biol 16:521-555.
17. Cruz LJ, Gray WR, Olivera BM. 1978. Purification and properties of a myotoxin from Conus geographus venom. Arch Biochem Biophys 190:539-548.
18. De Jongh KS, Warner C, Catterall WA. 1990. Subunits of purified calcium channels. Alpha 2 and delta are encoded by the same gene. J Biol Chem 265:14738-14741.
19. Destexhe A. 1998. Spike-and-wave oscillations based on the properties of GABAB receptors. J Neurosci 18:9099-9111.
20. Dolphin AC. 1995. The G.L. Brown Prize Lecture. Voltage-dependent calcium channels and their modulation by neurotransmitters and G proteins. Exp Physiol 80:1-36.
21. Ellinor PT, Zhang JF, Horne WA, Tsien RW. 1994. Structural determinants of the blockade of N-type calcium channels by a peptide neurotoxin. Nature 372:272-275.
22. Ellinor PT, Zhang JF, Randall AD, Zhou M, Schwarz TL, Tsien RW, Horne WA. 1993. Functional expression of a rapidly inactivating neuronal calcium channel. Nature 363:455-458.
23. Elmslie KS. 1997. Identification of the single channels that underlie the N-type and L-type calcium currents in bullfrog sympathetic neurons. J Neurosci 17:2658-2668.
24. Ertel EA, Campbell KP, Harpold MM, Hofmann F, Mori Y, Perez-Reyes E, Schwartz A, Snutch TP, Tanabe T, Birnbaumer L, Tsien RW, Catterall WA. 2000. Nomenclature of voltage-gated calcium channels. Neuron 25:533-535.
25. Escayg A, De Waard M, Lee DD, Bichet D, Wolf P, Mayer T, Johnston J, Baloh R, Sander T, Meisler MH. 2000. Coding and noncoding variation of the human calcium-channel beta4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia. Am J Hum Genet 66:1531-1539.
26. Feng ZP, Hamid J, Doering C, Bosey GM, Snutch TP, Zamponi GW. 2001. Residue Gly1326 of the N-type calcium channel alpha 1B subunit controls reversibility of omega-conotoxin GVIA and MVIIA block. J Biol Chem 276:15728-15735.
27. Gasparini S, Kasyanov AM, Pietrobon D, Voronin LL, Cherubini E. 2001. Presynaptic R-type calcium channels contribute to fast excitatory synaptic transmission in the rat hippocampus. J Neurosci 21:8715-8721.
28. Gurnett CA, De Waard M, Campbell KP. 1996. Dual function of the voltage-dependent Ca2+ channel alpha2delta subunit in current stimulation and subunit interaction. Neuron 16:431-440.
29. Gustafsson F, Andreasen D, Salomonsson M, Jensen BL, Holstein-Rathlou NH. 2001. Conducted vasoconstriction in rat mesenteric arterioles: role for dihydropyridine-insensitive Ca2+ channels. Am J Physiol Heart Circ Physiol 280:582-590.
30. Harvey AL. 2002. Toxins "R" Us: more pharmacological tools from nature's superstore. Trends Pharmacol Sci 23:201-203.
31. Heady TN, Gomora JC, Macdonald TL, Perez-Reyes E. 2001. Molecular pharmacology of T-type Ca2+ channels. Jpn J Pharmacol 85:339-350.
32. Hernandez-Hernandez R, Velasco M, Armas-Hernandez MJ, Armas-Padilla MC. 2002. Update on the use of calcium antagonists on hypertension. J Hum Hypertens 16(Suppl):114-117.
33. Hillyard DR, Monje VD, Mintz IM, Bean BP, Nadasdi L, Ramachandran J, Miljanich G, Azimi-Zoonooz A, McIntosh JM, Cruz LJ, et al. 1992. A new Conus peptide ligand for mammalian presynaptic Ca2+ channels. Neuron 9:69-77.
34. Hu H, Marban E. 1998. Isoform-specific inhibition of L-type calcium channels by dihydropyridines is independent of isoform-specific gating properties. Mol Pharmacol 53:902-907.
35. Jaggar JH, Porter VA, Lederer WJ, Nelson MT. 2000. Calcium sparks in smooth muscle. Am J Physiol Cell Physiol 278:235-256.
36. Jaggar JH, Wellman GC, Heppner TJ, Porter VA, Perez GJ, Gollasch M, Kleppisch T, Rubart M, Stevenson AS, Lederer WJ, Knot HJ, Bonev AD, Nelson MT. 1998. Ca2+ channels, ryanodine receptors and Ca(2+)-activated K+ channels: a functional unit for regulating arterial tone. Acta Physiol Scand 164:577-587.
37. Jay S, Sharp A, Kahl S, Vedvick T, Harpold M, Campbell K. 1991. Structural characterization of the dihydropyridine-sensitive calcium channel alpha 2-subunit and the associated delta peptides. J Biol Chem 266:3287-3293.
38. Jones SW, Jacobs LS. 1990. Dihydropyridine actions on calcium currents of frog sympathetic neurons. J Neurosci 10:2261-2267.
39. Jones SW, Marks TN. 1989a. Calcium currents in bullfrog sympathetic neurons. I. Activation kinetics and pharmacology. J Gen Physiol 94:151-167.
40. Jones SW, Marks TN. 1989b. Calcium currents in bullfrog sympathetic neurons. II. Inactivation. J Gen Physiol 94:169-182.
41. Kang MG, Campbell KP. 2003. Gamma subunit of voltage-activated calcium channels. J Biol Chem 278:21315-21318.
42. Kang MG, Chen CC, Felix R, Letts VA, Frankel WN, Mori Y, Campbell KP. 2001. Biochemical and biophysical evidence for gamma 2 subunit association with neuronal voltage-activated Ca2+ channels. J Biol Chem 276:32917-32924.
43. Kim C, Jun K, Lee T, Kim SS, McEnery MW, Chin H, Kim HL, Park JM, Kim DK, Jung SJ, Kim J, Shin HS. 2001. Altered nociceptive response in mice deficient in the alpha(1B) subunit of the voltage-dependent calcium channel. Mol Cell Neurosci 18:235-245.
44. Koschak A, Reimer D, Huber I, Grabner M, Glossmann H, Engel J, Striessnig J. 2001. alpha 1D (Cav1.3) subunits can form L-type Ca2+ channels activating at negative voltages. J Biol Chem 276:22100-22106.
45. Koschak A, Reimer D, Walter D, Hoda JC, Heinzle T, Grabner M, Striessnig J. 2003. Cav1.4alpha1 subunits can form slowly inactivating dihydropyridine-sensitive L-type Ca2+ channels lacking Ca2+-dependent inactivation. J Neurosci 23:6041-6049.
46. Krayenbuhl JC, Vozeh S, Kondo-Oestreicher M, Dayer P. 1999. Drug-drug interactions of new active substances: mibefradil example. Eur J Clin Pharmacol 55:559-565.
47. Lee HK, Elmslie KS. 1999. Gating of single N-type calcium channels recorded from bullfrog sympathetic neurons. J Gen Physiol 113:111-124.
48. Letts VA, Felix R, Biddlecome GH, Arikkath J, Mahaffey CL, Valenzuela A, Bartlett FS, 2nd, Mori Y, Campbell KP, Frankel WN. 1998. The mouse stargazer gene encodes a neuronal Ca2+-channel gamma subunit. Nat Genet 19:340-347.
49. Lewis RJ, Nielsen KJ, Craik DJ, Loughnan ML, Adams DA, Sharpe IA, Luchian T, Adams DJ, Bond T, Thomas L, Jones A, Matheson JL, Drinkwater R, Andrews PR, Alewood PF. 2000. Novel omega-conotoxins from Conus catus discriminate among neuronal calcium channel subtypes. J Biol Chem 275:35335-35344.
50. Liang H, Elmslie KS. 2002. Rapid and reversible block of N-type calcium channels (CaV 2.2) by omega-conotoxin GVIA in the absence of divalent cations. J Neurosci 22:8884-8890.
51. Lin Z, Lin Y, Schorge S, Pan JQ, Beierlein M, Lipscombe D. 1999. Alternative splicing of a short cassette exon in alpha1B generates functionally distinct N-type calcium channels in central and peripheral neurons. J Neurosci 19:5322-5331.
52. Luo ZD, Calcutt NA, Higuera ES, Valder CR, Song YH, Svensson CI, Myers RR. 2002. Injury type-specific calcium channel alpha 2delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. J Pharmacol Exp Ther 303:1199-1205.
53. Luo ZD, Chaplan SR, Higuera ES, Sorkin LS, Stauderman KA, Williams ME, Yaksh TL. 2001. Upregulation of dorsal root ganglion (alpha)2(delta) calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats. J Neurosci 21:1868-1875.
54. Mangoni ME, Couette B, Bourinet E, Platzer J, Reimer D, Striessnig J, Nargeot J. 2003. Functional role of L-type Cav1.3 Ca2+ channels in cardiac pacemaker activity. Proc Natl Acad Sci USA 100:5543-5548.
55. Mao J, Chen LL. 2000. Gabapentin in pain management. Anesth Analg 91:680-687.
56. Marais E, Klugbauer N, Hofmann F. 2001. Calcium channel alpha 2delta subunits - structure and gabapentin binding. Mol Pharmacol 59:1243-1248.
57. Mariot P, Vanoverberghe K, Lalevee N, Rossier MF, Prevarskaya N. 2002. Overexpression of an alpha 1H (Cav3.2) T-type calcium channel during neuroendocrine differentiation of human prostate cancer cells. J Biol Chem 277:10824-10833.
58. Martin RL, Lee JH, Cribbs LL, Perez-Reyes E, Hanck DA. 2000. Mibefradil block of cloned T-type calcium channels. J Pharmacol Exp Ther 295:302-308.
59. Matthews EA, Dickenson AH. 2001. Effects of spinally delivered N- and P-type voltage-dependent calcium channel antagonists on dorsal horn neuronal responses in a rat model of neuropathy. Pain 92:235-246.
60. McCormick DA, Contreras D. 2001. On the cellular and network bases of epileptic seizures. Annu Rev Physiol 63:815-846.
61. McDonough SI, Bean BP. 1998. Mibefradil inhibition of T-type calcium channels in cerebellar purkinje neurons. Mol Pharmacol 54:1080-1087.
62. McDonough SI, Boland LM, Mintz IM, Bean BP. 2002. Interactions among toxins that inhibit N-type and P-type calcium channels. J Gen Physiol 119:313-328.
63. McDonough SI, Mintz IM, Bean BP. 1997. Alteration of P-type calcium channel gating by the spider toxin omega-Aga-IVA. Biophys J 72:2117-2128.
64. Messerli FH. 2002. Calcium antagonists in hypertension: from hemodynamics to outcomes. Am J Hypertens 15:94-97.
65. Mintz IM, Venema VJ, Swiderek KM, Lee TD, Bean BP, Adams ME. 1992. P-type calcium channels blocked by the spider toxin omega-Aga-IVA. Nature 355:827-829.
66. Moore KA, Baba H, Woolf CJ. 2002. Gabapentin - actions on adult superficial dorsal horn neurons. Neuropharmacology 43:1077-1081.
67. Morgans CW, Gaughwin P, Maleszka R. 2001. Expression of the alpha1F calcium channel subunit by photoreceptors in the rat retina. Mol Vis 7:202-209.
68. Nelson MT, Patlak JB, Worley JF, Standen NB. 1990. Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone. Am J Physiol 259:3-18.
69. Newcomb R, Szoke B, Palma A, Wang G, Chen X, Hopkins W, Cong R, Miller J, Urge L, Tarczy-Hornoch K, Loo JA, Dooley DJ, Nadasdi L, Tsien RW, Lemos J, Miljanich G. 1998. Selective peptide antagonist of the class E calcium channel from the venom of the tarantula Hysterocrates gigas. Biochemistry 37:15353-15362.
70. Olivera BM, Cruz LJ, de Santos V, LeCheminant GW, Griffin D, Zeikus R, McIntosh JM, Galyean R, Varga J, Gray WR, et al. 1987. Neuronal calcium channel antagonists. Discrimination between calcium channel subtypes using omega-conotoxin from Conus magus venom. Biochemistry 26:2086-2090.
71. Olivera BM, Gray WR, Zeikus R, McIntosh JM, Varga J, Rivier J, de Santos V, Cruz LJ. 1985. Peptide neurotoxins from fish-hunting cone snails. Science 230:1338-1343.
72. Papatsonis DN, Van Geijn HP, Ader HJ, Lange FM, Bleker OP, Dekker GA. 1997. Nifedipine and ritodrine in the management of preterm labor: a randomized multicenter trial. Obstet Gynecol 90:230-234.
73. Papatsonis DN, van Geijn HP, Bleker OP, Ader HJ, Dekker GA. 2003. Hemodynamic and metabolic effects after nifedipine and ritodrine tocolysis. Int J Gynecol Obstet 82:5-10.
74. Park D, Dunlap K. 1998. Dynamic regulation of calcium influx by G-proteins, action potential waveform, and neuronal firing frequency. J Neurosci 18:6757-6766.
75. Patel MK, Gonzalez MI, Bramwell S, Pinnock RD, Lee K. 2000. Gabapentin inhibits excitatory synaptic transmission in the hyperalgesic spinal cord. Br J Pharmacol 130:1731-1734.
76. Penn RD, Paice JA. 2000. Adverse effects associated with the intrathecal administration of ziconotide. Pain 85:291-296.
77. Perez-Reyes E. 2003. Molecular physiology of low-voltage-activated T-type calcium channels. Physiol Rev 83:117-161.
78. Pietrobon D, Striessnig J. 2003. Neurobiology of migraine. Nat Rev Neurosci 4:386-398.
79. Platzer J, Engel J, Schrott-Fischer A, Stephan K, Bova S, Chen H, Zheng H, Striessnig J. 2000. Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels. Cell 102:89-97.
80. Plummer MR, Logothetis DE, Hess P. 1989. Elementary properties and pharmacological sensitivities of calcium channels in mammalian peripheral neurons. Neuron 2:1453-1463.
81. Prado WA. 2001. Involvement of calcium in pain and antinociception. Braz J Med Biol Res 34:449-461.
82. Qin N, Yagel S, Momplaisir ML, Codd EE, D'Andrea MR. 2002. Molecular cloning and characterization of the human voltage-gated calcium channel alpha 2delta-4 subunit. Mol Pharmacol 62:485-496.
83. Randall A, Tsien RW. 1995. Pharmacological dissection of multiple types of Ca2+ channel currents in rat cerebellar granule neurons. J Neurosci 15:2995-3012.
84. Russo CM, Brose WG. 1998. Chronic pain, Annu Rev Med 49:123-133.
85. Saegusa H, Kurihara T, Zong S, Kazuno A, Matsuda Y, Nonaka T, Han W, Toriyama H, Tanabe T. 2001. Suppression of inflammatory and neuropathic pain symptoms in mice lacking the N-type Ca2+ channel. EMBO J 20:2349-2356.
86. Safa P, Boulter J, Hales TG. 2001. Functional properties of CaV1.3 (alpha 1D) L-type Ca2+ channel splice variants expressed by rat brain and neuroendocrine GH3 cells. J Biol Chem 276:38727-38737.
87. Sanger GJ, Ellis ES, Harries MH, Tilford NS, Wardle KA, Benham CD. 2000. Rank-order inhibition by omega-conotoxins in human and animal autonomic nerve preparations. Eur J Pharmacol 388:89-95.
88. Sanguinetti MC, Kass RS. 1984. Voltage-dependent block of calcium channel current in the calf cardiac Purkinje fiber by dihydropyridine calcium channel antagonists. Circ Res 55:336-348.
89. Scholze A, Plant TD, Dolphin AC, Nurnberg B. 2001. Functional expression and characterization of a voltage-gated CaV1.3 (alpha1D) calcium channel subunit from an insulin-secreting cell line. Mol Endocrinol 15:1211-1221.
90. Scott DA, Wright CE, Angus JA. 2002. Actions of intrathecal omega-conotoxins CVID, GVIA, MVIIA, and morphine in acute and neuropathic pain in the rat. Eur J Pharmacol 451:279-286.
91. Shimoyama M, Shimoyama N, Hori Y. 2000. Gabapentin affects glutamatergic excitatory neurotransmission in the rat dorsal horn. Pain 85:405-414.
92. Smith MT, Cabot PJ, Ross FB, Robertson AD, Lewis RJ. 2002. The novel N-type calcium channel blocker, AM336, produces potent dose-dependent antinociception after intrathecal dosing in rats and inhibits substance P release in rat spinal cord slices. Pain 96:119-127.
93. Stocker JW, Nadasdi L, Aldrich RW, Tsien RW. 1997. Preferential interaction of omega-conotoxins with inactivated N-type Ca2+ channels. J Neurosci 17:3002-3013.
94. Striessnig J, Grabner M, Mitterdorfer J, Hering S, Sinnegger MJ, Glossmann H. 1998. Structural basis of drug binding to L Ca2+ channels. Trends Pharmacol Sci 19:108-115.
95. Strom TM, Nyakatura G, Apfelstedt-Sylla E, Hellebrand H, Lorenz B, Weber BH, Wutz K, Gutwillinger N, Ruther K, Drescher B, Sauer C, Zrenner E, Meitinger T, Rosenthal A, Meindl A. 1998. An L-type calcium-channel gene mutated in incomplete X-linked congenital stationary night blindness. Nat Genet 19:260-263.
96. Sutton KG, Martin DJ, Pinnock RD, Lee K, Scott RH. 2002. Gabapentin inhibits high-threshold calcium channel currents in cultured rat dorsal root ganglion neurones. Br J Pharmacol 135:257-265.
97. Swandulla D, Armstrong CM. 1988. Fast-deactivating calcium channels in chick sensory neurons. J Gen Physiol 92:197-218.
98. Toescu EC. 1999. Activity of voltage-operated calcium channels in rat cerebellar granule neurons and neuronal survival. Neuroscience 94:561-570.
99. Tottene A, Volsen S, Pietrobon D. 2000. alpha(1E) subunits form the pore of three cerebellar R-type calcium channels with different pharmacological and permeation properties. J Neurosci 20:171-178.
100. Turner TJ, Adams ME, Dunlap K. 1993. Multiple Ca2+ channel types coexist to regulate synaptosomal neurotransmitter release. Proc Natl Acad Sci USA 90:9518-9522.
101. VanBavel E, Sorop O, Andreasen D, Pfaffendorf M, Jensen BL. 2002. Role of T-type calcium channels in myogenic tone of skeletal muscle resistance arteries. Am J Physiol Heart Circ Physiol 283:2239-2243.
102. Vanegas H, Schaible HG. 2000. Effects of antagonists to high-threshold calcium channels upon spinal mechanisms of pain, hyperalgesia and allodynia. Pain 85:9-18.
103. Walker D, De Waard M. 1998. Subunit interaction sites in voltage-dependent Ca2+ channels: role in channel function. Trends Neurosci 21:148-154.
104. Welling A, Ludwig A, Zimmer S, Klugbauer N, Flockerzi V, Hofmann F. 1997. Alternatively spliced IS6 segments of the (alpha)1C gene determine the tissue-specific dihydropyridine sensitivity of cardiac and vascular smooth muscle L-type Ca2+ channels. Circ Res 81:526-532.
105. Williams M, Kowaluk EA, Arneric SP. 1999. Emerging molecular approaches to pain therapy. J Med Chem 42:1481-1500.
106. Xu W, Lipscombe D. 2001. Neuronal Ca(V)1.3alpha(1) L-type channels activate at relatively hyperpolarized membrane potentials and are incompletely inhibited by dihydropyridines. J Neurosci 21:5944-5951.
107. Yan Z, Chi P, Bibb JA, Ryan TA, Greengard P. 2002. Roscovitine: a novel regulator of P/Q-type calcium channels and transmitter release in central neurons. J Physiol (Lond) 540:761-770.
108. Zhang Y, Mori M, Burgess DL, Noebels JL. 2002a. Mutations in high-voltage-activated calcium channel genes stimulate low-voltage-activated currents in mouse thalamic relay neurons. J Neurosci 22:6362-6371.
109. Zhang Z, Xu Y, Song H, Rodriguez J, Tuteja D, Namkung Y, Shin H-S, Chiamvimonvat N. 2002b. Functional roles of Cav1.3 (alpha)1D calcium channel in sinoatrial nodes: insight gained using gene-targeted null mutant mice. Circ Res 90:981-987.